IP Verse

Sanofi Biotechnologies vs. Amgen - UPC_CFI_505/2023

The case UPC_CFI_505/2023 was filed by the plaintiff Sanofi Biotechnologies against the defendant Amgen on 10 Jan, 2024.

Case Timeline

10 Jan, 2024
Case Filed
03 May, 2024
Counterclaim for Revocation
19 Feb, 2025
Written Procedure
19 Feb, 2025
Interim Conference
19 Feb, 2025
Oral Procedure
Today Nov 1, 2025
Decision

Case Details

    Case Number:

    UPC_CFI_505/2023

    Patent Number:

    EP3536712

    Filing Date:

    10 Jan, 2024

    Proceeding Type:

    Infringement

    Case Phase:

    Case Closed

    Plaintiffs:

    • Sanofi Biotechnologies

    Plaintiff Representative:

    • Niels Hoelder

    Defendants:

    • Amgen

    Defendant Representative:

    • Johannes Heselberger

    Judges:

    • Andras Kupecz
    • Berenice Thom
    • Ronny Thomas
    • Xavier Dorland-Galliot

    Court Division:

    First Instance, Local Division - Dusseldorf

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

Last updated on: Oct 30, 2025
DateTitle

Notify me when new UPC document is filed

Jun 27, 2025Receipt
Jun 23, 2025250623 Request Re. Audio Recording
Jun 16, 2025Workflow Closed
Jun 16, 2025Outcome Of The Order
Jun 13, 2025Receipt
Jun 13, 202520250613 Application Cost Decision Amgen
May 13, 2025Headnote And Keywords
May 13, 2025Final Decision
May 13, 2025Decisionoutcome
Apr 30, 2025Outcome Of The Order
Apr 30, 2025Confirmation Of Appointment
Apr 22, 2025Receipt
Apr 17, 202520250417 Recording Of Oral Hearing Request Amgen En
Apr 4, 2025Reschedule Announcement
Mar 3, 2025Request For Correction
Mar 3, 2025Receipt
Mar 3, 2025250227 Email Re Correction
Mar 3, 2025250214 Order Correction Of Claimant'S Name
Feb 26, 2025597355/Oh/Dus Loc/Upc202502250930Am/S04
Feb 26, 2025597355/Oh/Dus Loc/Upc202502250930Am/S03
Feb 26, 2025597355/Oh/Dus Loc/Upc202502250930Am/S02
Feb 26, 2025597355/Oh/Dus Loc/Upc202502250930Am/S01
Feb 21, 2025Summon Oral Hearing
Feb 21, 2025Summary Of Citations
Feb 21, 2025Response On Requests And Synoptical Table
Feb 21, 2025New Upload Due To Technical Reasons
Feb 21, 2025Interim Procedure Closure
Feb 21, 2025Hearing Dates
Feb 21, 2025Exhibit Bp 85 Amgen
Feb 21, 202520250221 Table Of Exhibits And Request Ars Brief Amgen
Feb 20, 2025Rejecting Time Extension
Feb 20, 2025Rectification Order
Feb 20, 2025Outcome Of The Order
Feb 20, 2025Course Of The Oral Hearing
Feb 19, 2025Written Procedure Closure
Feb 19, 2025Template Order
Feb 19, 2025Receipt
Feb 19, 2025Outcome Of The Order
Feb 19, 2025Order Interim Procedure
Feb 19, 2025Art. 33 3)(A) Upca
Feb 18, 2025Slides For The Hearing On 25 February
Feb 18, 2025Request On Timing Of Complete Statement Of Claim
Feb 18, 2025Receipt
Feb 18, 2025Exhibit Bp84 Amgen
Feb 18, 2025Cover Letter On Submssion Of Slides
Feb 18, 202520250218 Response Amgen App 6226 2025
Feb 18, 202520250218 Comment Re Cfr Amgen App 5925 2025 En Signed
Feb 14, 2025Outcome Of The Order
Feb 14, 2025Opportunity To Comment
Feb 14, 2025Decision Regarding R.9 Request
Feb 14, 2025Correction Name
Feb 6, 2025Receipt
Feb 5, 2025Receipt
Feb 5, 2025He 116A
Feb 5, 2025Application Pursuant To Rule 9.1 Rop
Feb 5, 20253Rd Prof. Parhofer Declaration
Feb 4, 2025Sanofi V Amgen Rule 336 Rop Request To File Demonstratives
Feb 3, 2025Rectification
Jan 30, 2025Separation Of Proceedings
Jan 21, 2025Receipt
Jan 20, 2025Response Re Separation Of EP857 And Value In Litigation
Jan 20, 2025Receipt
Jan 20, 2025250120 Reply To Order On Separation And VALUE Of Action
Dec 23, 2024R. 20.2 Rop Information
Dec 23, 2024Preliminary Objection Decisionoutcome
Dec 13, 2024Order Set Date And Summon To Oral Hearing
Dec 13, 2024Hearing Dates
Dec 5, 2024Panel Appointment
Nov 29, 2024Outcome Of The Order
Nov 29, 2024Order Inform Pcfi Allocation Tqj
Nov 14, 2024Receipt
Nov 13, 2024Exhibit Bp83 Court Notice Re Re Scheduled Oral Hearing In Main Damages Case
Nov 13, 2024Exhibit Bp82 Minutes Oral Hearing In Main Damages Case
Nov 13, 2024Application To Comment Re. Scheduling Nov 13
Nov 11, 2024He 115 241016 Munich Court Order
Nov 11, 2024He 114 Confirmation Ski Rauline (Redacted)
Nov 11, 2024241111 Comments
Nov 11, 202420241111 Request For Hearing Date Brief Of Amgen
Nov 5, 2024Pre Order Opportunity To Comment Oral Hearing Date
Oct 21, 2024Receipt
Oct 18, 2024EP857Reply To Amgen Response To Application For Leave To Amend Case (Signed)
Oct 9, 2024Response To Application For Leave To Amend The Case R263
Oct 9, 2024Receipt
Oct 8, 2024241008 Submission On Lis Pendens
Oct 4, 2024Receipt
Oct 4, 2024Correction
Oct 3, 2024Application
Sep 26, 2024Order Opportunity To Comment
Sep 25, 2024Receipt
Sep 25, 2024He 107 Confirmatory License Agreement
Sep 25, 2024He 105 Intention To Grant
Sep 25, 2024He 104 Decision To Grant
Sep 25, 2024Exhibit He 109
Sep 25, 2024Exhibit He 108
Sep 25, 2024Exhibit He 106
Sep 25, 2024Application To Amend Case
Sep 23, 2024Infringement Rejoinder And Validity Reply
Sep 23, 2024Exhibit Bp81
Sep 23, 2024Exhibit Bp80
Sep 23, 2024Exhibit Bp79
Sep 23, 2024Exhibit Bp78
Sep 23, 2024Exhibit Bp77
Sep 23, 2024Exhibit Bp76
Sep 23, 2024Exhibit Bp75
Sep 23, 2024Acknowledgement Of Lodging
Jul 22, 2024Reply To Defence And Defence To Counterclaim
Jul 22, 2024He 99 Szarek
Jul 22, 2024He 98 Safarova
Jul 22, 2024He 97 Declaration Of Prof Di Angelantonio
Jul 22, 2024He 96 Swergold Poster
Jul 22, 2024He 95 Lagor And Millar
Jul 22, 2024He 94 Excerpt From Clinicaltrials Gov Amg145
Jul 22, 2024He 93 Excerpt From Clinicaltrials Gov Gauss
Jul 22, 2024He 92 Declaration Of Prof Parhofer On Validity
Jul 22, 2024He 91 Nct012884443
Jul 22, 2024He 90 Repatha Fda Approval
Jul 22, 2024He 89 Praluent Fda Approval
Jul 22, 2024He 88 Kamstrup
Jul 22, 2024He 87 Jama
Jul 22, 2024He 86 Cohen
Jul 22, 2024He 85 Romangnuolo
Jul 22, 2024He 84 Stroes
Jul 22, 2024He 83 Albers (Aim High)
Jul 22, 2024He 82 Willeit
Jul 22, 2024He 81 Sabatine
Jul 22, 2024He 80 Schwartz
Jul 22, 2024He 79 Ober
Jul 22, 2024He 78 Cohen
Jul 22, 2024He 77 Colhoun
Jul 22, 2024He 76 Lambert
Jul 22, 2024He 75 Schmidt
Jul 22, 2024He 74 Soutar 1991
Jul 22, 2024He 73 Lamon Fava
Jul 22, 2024He 72 Anuurad
Jul 22, 2024He 71 Rader 1995
Jul 22, 2024He 70 Hobbs 1999
Jul 22, 2024He 69 Kolski
Jul 22, 2024He 68 Koschinsky And Boffa
Jul 22, 2024He 67 Kochinsky And Marcovina
Jul 22, 2024He 66 Jacobson
Jul 22, 2024He 65 Dube
Jul 22, 2024He 64 Clarke
Jul 22, 2024He 63 Kamstrup
Jul 22, 2024He 62 Tregouet
Jul 22, 2024He 61 Davignon
Jul 22, 2024He 60 Lippi
Jul 22, 2024He 59 Bonny Eingetreten Im November Sanofi Biotechnology Sas (Fr)
Jul 22, 2024He 59A En
Jul 22, 2024He 58 Confirmation Of Power To Act July 16
Jul 22, 2024He 58A Coury Witness Statement 18 July
Jul 22, 2024He 57 Laurent Gilhodes As Chairman Of Sanofi Biotechnologies Sas (Fr)
Jul 22, 2024He 57A En
Jul 22, 2024He 56 Second Confirmatory License Agreement
Jul 22, 2024He 55 Poa Executed By Gilhodes (Fr)
Jul 22, 2024He 55A En
Jul 22, 2024He 54 Form 8 K Filing To Us Sec April 7
Jul 22, 2024He 53 2Nd Parhofer Declaration Infringment
Jul 22, 2024He 52 Smpc Atorvastatin (De)
Jul 22, 2024He 51 Chmp
Jul 22, 2024He 51A Report From The Cmdh Meeting Held On 16Th 17Th And 18Th January
Jul 22, 2024He 50 Statement Of Defence (De)
Jul 22, 2024He 50A En
Jul 22, 2024He 49 Smpc Training Presentation Of The Emas Smpc Advisory Group
Jul 22, 2024He 48 C Ronse
Jul 22, 2024He 47 Paris 20 Ocober 1913662 (Fr)
Jul 22, 2024He 47A En
Jul 22, 2024He 46 O Donoghue Et Al Circulation
Jul 22, 2024He 46A O Donoghue Et Al Supplemental Material
Jul 22, 2024He 45 Amgens Reply Of 25 April
Jul 22, 2024He 45A En
Jul 22, 2024He 40B Verification Of Electronic Signatures For He 40
Jul 22, 2024He 38A Verification Of Electronic Signatures For He 38
Jul 22, 2024He 103 Stein
Jul 22, 2024He 102 Smpc For Praluent ()
Jul 22, 2024He 101 Smpc For Repatha ()
Jul 22, 2024He 100 Summary Of Pre Priority Clinical Trials Using Anti Pcsk9 Antibodies
Jul 22, 2024Ar 5 Clean
Jul 22, 2024Ar 5B Amended Description
Jul 22, 2024Ar 5A Tracked
Jul 22, 2024Ar 4 Clean
Jul 22, 2024Ar 4B Amended Description
Jul 22, 2024Ar 4A Tracked
Jul 22, 2024Ar 3 Clean
Jul 22, 2024Ar 3B Amended Description
Jul 22, 2024Ar 3A Tracked
Jul 22, 2024Ar 2 Clean
Jul 22, 2024Ar 2B Amended Description
Jul 22, 2024Ar 2A Tracked
Jul 22, 2024Ar 1 Clean
Jul 22, 2024Ar 1B Amended Description
Jul 22, 2024Ar 1A Tracked
Jul 22, 2024Acknowledgement Of Lodging
Jul 1, 2024Response On Time Extension Request From Sanofi
Jul 1, 2024Procedural Order Extension Time Limit
Jul 1, 2024Outcome Of The Order
Jun 26, 2024Receipt
Jun 26, 2024Opportunity To Comment
Jun 25, 2024.06.25 Request For An Extension
Jun 20, 2024Fruther Brief Re Preliminary Objection En
Jun 20, 2024Exhibit Bp74
Jun 18, 2024He 44 Rc Dusseldorf Order Of 3 May
Jun 18, 2024He 44A Translation He 44
Jun 18, 2024He 43 Rc Dusseldorf Order Of 13 May
Jun 18, 2024He 43A Translation He 43
Jun 18, 2024240517 Notice Re Preliminary Objection Sgn
Jun 17, 2024Case Management Preliminary Objection
May 21, 2024Request To Produce Evidence
May 21, 2024Receipt
May 17, 2024Receipt
May 17, 2024Notice Re Po
May 17, 2024He 44A
May 17, 2024He 44
May 17, 2024He 43A
May 17, 2024He 43
May 6, 2024Formal Checks Notification Of Positive Outcome
May 3, 2024Statement Of Defense And Counterclaim For Revocation Amgen May 3 2024 En Signed
May 3, 2024Statement Of Defense
May 3, 2024Exhibit Bp9
May 3, 2024Exhibit Bp8
May 3, 2024Exhibit Bp73 Amgen En
May 3, 2024Exhibit Bp73
May 3, 2024Exhibit Bp72 Amgen En
May 3, 2024Exhibit Bp72
May 3, 2024Exhibit Bp71 Amgen En
May 3, 2024Exhibit Bp71
May 3, 2024Exhibit Bp70 Amgen De
May 3, 2024Exhibit Bp70A Amgen En
May 3, 2024Exhibit Bp70A
May 3, 2024Exhibit Bp70
May 3, 2024Exhibit Bp7
May 3, 2024Exhibit Bp6 Part 4
May 3, 2024Exhibit Bp6 Part 3
May 3, 2024Exhibit Bp6 Part 2
May 3, 2024Exhibit Bp6 Part 1
May 3, 2024Exhibit Bp69 Amgen Be
May 3, 2024Exhibit Bp69A Amgen En
May 3, 2024Exhibit Bp69A
May 3, 2024Exhibit Bp69
May 3, 2024Exhibit Bp68 Amgen It
May 3, 2024Exhibit Bp68A Amgen En
May 3, 2024Exhibit Bp68A
May 3, 2024Exhibit Bp68
May 3, 2024Exhibit Bp67 Amgen Fr
May 3, 2024Exhibit Bp67A Amgen En
May 3, 2024Exhibit Bp67A
May 3, 2024Exhibit Bp67
May 3, 2024Exhibit Bp66 Amgen Nl
May 3, 2024Exhibit Bp66A Amgen En
May 3, 2024Exhibit Bp66A
May 3, 2024Exhibit Bp66
May 3, 2024Exhibit Bp65 Amgen En
May 3, 2024Exhibit Bp65
May 3, 2024Exhibit Bp64 Amgen De
May 3, 2024Exhibit Bp64A Amgen En
May 3, 2024Exhibit Bp64A
May 3, 2024Exhibit Bp64
May 3, 2024Exhibit Bp63 Amgen De
May 3, 2024Exhibit Bp63A Amgen En
May 3, 2024Exhibit Bp63A
May 3, 2024Exhibit Bp63
May 3, 2024Exhibit Bp62 Amgen De
May 3, 2024Exhibit Bp62
May 3, 2024Exhibit Bp61 Amgen En
May 3, 2024Exhibit Bp61
May 3, 2024Exhibit Bp60 Amgen De
May 3, 2024Exhibit Bp60A Amgen En
May 3, 2024Exhibit Bp60A
May 3, 2024Exhibit Bp60
May 3, 2024Exhibit Bp59 Amgen En
May 3, 2024Exhibit Bp59
May 3, 2024Exhibit Bp58 Amgen En
May 3, 2024Exhibit Bp58
May 3, 2024Exhibit Bp57 Amgen En
May 3, 2024Exhibit Bp57
May 3, 2024Exhibit Bp56 Part 2
May 3, 2024Exhibit Bp56 Part 1
May 3, 2024Exhibit Bp56 Amgen Part 2 Fr
May 3, 2024Exhibit Bp56 Amgen Part 1 Fr
May 3, 2024Exhibit Bp56A Amgen En
May 3, 2024Exhibit Bp56A
May 3, 2024Exhibit Bp55 Amgen En
May 3, 2024Exhibit Bp55
May 3, 2024Exhibit Bp54 Amgen En
May 3, 2024Exhibit Bp54
May 3, 2024Exhibit Bp53 Amgen De
May 3, 2024Exhibit Bp53A Amgen En
May 3, 2024Exhibit Bp53A
May 3, 2024Exhibit Bp53
May 3, 2024Exhibit Bp52 Amgen De
May 3, 2024Exhibit Bp52A Amgen En
May 3, 2024Exhibit Bp52A
May 3, 2024Exhibit Bp52
May 3, 2024Exhibit Bp51 Amgen It
May 3, 2024Exhibit Bp51A Amgen En
May 3, 2024Exhibit Bp51A
May 3, 2024Exhibit Bp51
May 3, 2024Exhibit Bp50 Amgen Fr
May 3, 2024Exhibit Bp50A Amgen En
May 3, 2024Exhibit Bp50A
May 3, 2024Exhibit Bp50
May 3, 2024Exhibit Bp5
May 3, 2024Exhibit Bp49 Amgen Fr
May 3, 2024Exhibit Bp49A Amgen En
May 3, 2024Exhibit Bp49A
May 3, 2024Exhibit Bp49
May 3, 2024Exhibit Bp48 Amgen Fr
May 3, 2024Exhibit Bp48A Amgen En
May 3, 2024Exhibit Bp48A
May 3, 2024Exhibit Bp48
May 3, 2024Exhibit Bp47 Amgen Nl
May 3, 2024Exhibit Bp47A Amgen En
May 3, 2024Exhibit Bp47A
May 3, 2024Exhibit Bp47
May 3, 2024Exhibit Bp46 Amgen Nl
May 3, 2024Exhibit Bp46A Amgen En
May 3, 2024Exhibit Bp46A
May 3, 2024Exhibit Bp46
May 3, 2024Exhibit Bp45 Amgen En
May 3, 2024Exhibit Bp45
May 3, 2024Exhibit Bp44 Amgen En
May 3, 2024Exhibit Bp44
May 3, 2024Exhibit Bp43 Amgen En
May 3, 2024Exhibit Bp43
May 3, 2024Exhibit Bp42 Amgen En
May 3, 2024Exhibit Bp42
May 3, 2024Exhibit Bp41 Amgen En
May 3, 2024Exhibit Bp41
May 3, 2024Exhibit Bp40 Amgen En
May 3, 2024Exhibit Bp40
May 3, 2024Exhibit Bp39 Amgen En
May 3, 2024Exhibit Bp39
May 3, 2024Exhibit Bp38 Amgen En
May 3, 2024Exhibit Bp38
May 3, 2024Exhibit Bp37 Amgen En
May 3, 2024Exhibit Bp37
May 3, 2024Exhibit Bp36 Amgen En
May 3, 2024Exhibit Bp36
May 3, 2024Exhibit Bp35 Amgen En
May 3, 2024Exhibit Bp35
May 3, 2024Exhibit Bp34 Amgen En
May 3, 2024Exhibit Bp34A Amgen En
May 3, 2024Exhibit Bp34A
May 3, 2024Exhibit Bp34
May 3, 2024Exhibit Bp33 Amgen De
May 3, 2024Exhibit Bp33A Amgen En
May 3, 2024Exhibit Bp33A
May 3, 2024Exhibit Bp33
May 3, 2024Exhibit Bp32 Amgen En
May 3, 2024Exhibit Bp32
May 3, 2024Exhibit Bp31 Amgen En
May 3, 2024Exhibit Bp31
May 3, 2024Exhibit Bp30 Amgen En
May 3, 2024Exhibit Bp30
May 3, 2024Exhibit Bp29 Amgen En
May 3, 2024Exhibit Bp29
May 3, 2024Exhibit Bp28 Amgen En
May 3, 2024Exhibit Bp28
May 3, 2024Exhibit Bp27 Amgen En
May 3, 2024Exhibit Bp27
May 3, 2024Exhibit Bp26 Amgen En
May 3, 2024Exhibit Bp26
May 3, 2024Exhibit Bp25 Amgen En
May 3, 2024Exhibit Bp25
May 3, 2024Exhibit Bp24 Amgen En
May 3, 2024Exhibit Bp24
May 3, 2024Exhibit Bp23 Amgen En
May 3, 2024Exhibit Bp23
May 3, 2024Exhibit Bp22 Amgen En
May 3, 2024Exhibit Bp22
May 3, 2024Exhibit Bp21 Amgen En
May 3, 2024Exhibit Bp21
May 3, 2024Exhibit Bp20 Amgen En
May 3, 2024Exhibit Bp20
May 3, 2024Exhibit Bp19 Amgen En
May 3, 2024Exhibit Bp19
May 3, 2024Exhibit Bp18 Amgen En
May 3, 2024Exhibit Bp18
May 3, 2024Exhibit Bp17 Amgen En
May 3, 2024Exhibit Bp17
May 3, 2024Exhibit Bp16 Amgen En
May 3, 2024Exhibit Bp16
May 3, 2024Exhibit Bp15 Amgen En
May 3, 2024Exhibit Bp15
May 3, 2024Exhibit Bp14 Amgen En
May 3, 2024Exhibit Bp14
May 3, 2024Exhibit Bp13 Amgen En
May 3, 2024Exhibit Bp13
May 3, 2024Exhibit Bp12 Amgen En
May 3, 2024Exhibit Bp12
May 3, 2024Exhibit Bp11 Amgen En
May 3, 2024Exhibit Bp11
May 3, 2024Exhibit Bp10 Amgen En
May 3, 2024Exhibit Bp10
May 3, 2024Exhibit Bp09 Amgen En
May 3, 2024Exhibit Bp08 Amgen En
May 3, 2024Exhibit Bp07 Amgen En
May 3, 2024Exhibit Bp06 Amgen Part 4 En
May 3, 2024Exhibit Bp06 Amgen Part 3 En
May 3, 2024Exhibit Bp06 Amgen Part 2 En
May 3, 2024Exhibit Bp06 Amgen Part 1 En
May 3, 2024Exhibit Bp05 Amgen En
May 3, 2024Acknowledgement Of Lodging
Mar 18, 2024Response To Preliminary Objection
Mar 18, 2024Federal Patent Court, Summons And Preliminary Opinion In Accordance With Sec. 83 German Patent Act
Mar 18, 2024Commentpreliminaryobjection
Mar 4, 2024Preliminary Objection
Mar 4, 2024Preliminaryobjection
Mar 4, 2024Exhibit Bp04A
Mar 4, 2024Exhibit Bp04
Mar 4, 2024Exhibit Bp03A
Mar 4, 2024Exhibit Bp03
Mar 4, 2024Exhibit Bp02A
Mar 4, 2024Exhibit Bp02
Mar 4, 2024Exhibit Bp01A
Mar 4, 2024Exhibit Bp01
Feb 9, 2024Epouploaddocumentsworkflow
Feb 9, 2024Document From Epo
Feb 5, 2024Notification Of Service
Feb 5, 2024Acknowledgement Of Access To Case
Jan 25, 2024Receipt
Jan 25, 2024Panel Appointment
Jan 25, 2024Formal Checks Notification Of Positive Outcome
Jan 25, 2024Epo Request For Case Pending
Jan 10, 2024Proof Of Payment
Jan 10, 2024He 9 Amgen S Submissions On Infringement Of Ep 004 Before The Rc Dusseldorf (Bundle)
Jan 10, 2024He 8 Claimants Submissions On Infringement Of Ep 004 Before The Rc Dusseldorf (Bundle)
Jan 10, 2024He 7 Board Of Appeal (T1927/22 3.3.04), Minutes Of The Hearing On 6 December
Jan 10, 2024He 6 Board Of Appeal (T1927/22 3.3.04), Preliminary Opinion On Ep 004 Of 6 October
Jan 10, 2024He 5 Opposition Division, Grounds For The Decision On Ep 004 Of 16 August
Jan 10, 2024He 4 Notice On The Outcome Of The Opposition On Ep 004 Of 8/9 June
Jan 10, 2024He 41 Appointment Alban De La Sabliere
Jan 10, 2024He 40 Power Of Attorney John C. Conway (French)
Jan 10, 2024He 40A Translation He 40 (En)
Jan 10, 2024He 3 EP2756004B1
Jan 10, 2024He 39 Appointment Larry Coury Secretary Certificate
Jan 10, 2024He 38 Confirmatory License Agreement
Jan 10, 2024He 37 Lauer Taxe Excerpt
Jan 10, 2024He 36 Press Release Of Defendant 1) Of 21. February
Jan 10, 2024He 35 Press Release Of Defendant 1) Of 21. July
Jan 10, 2024He 34 EP2215124B9 (Excerpt)
Jan 10, 2024He 33 Amgen Inc., Annual Report (10 K Filing) For Fiscal Year Ended December 31, (Excerpt)
Jan 10, 2024He 32 Parhofer Kg Et Al, Drugs Real World Outcomes ; 6: 115 123
Jan 10, 2024He 31 Ema, Chmp, Chmp DAY 120 List Of Questions, Evolocumab Amgen Europe B.V., Ema/Chmp/33068 (Excerpt)
Jan 10, 2024He 30 Ema, Chmp, Assessment Report Repatha(R), Ema/Chmp/222019 (Excerpt)
Jan 10, 2024He 2 Printouts From Patent Register [Bundle]
Jan 10, 2024He 29 Cmdh Questions & Answers On Usage Patents, Cmdh/279, Rev. 1, May
Jan 10, 2024He 28 Case T452/14, Laboratoires Ctrs V European Commission, Ecli:Eu:T::373
Jan 10, 2024He 27 Ema S Guideline On Summary Of Product Characteristics (Smpc) Of September
Jan 10, 2024He 26 Hoge Raad, Judgement Of 3 November , 15/04934, Ecli:Nl:Hr::2807
Jan 10, 2024He 26A English Translation (En)
Jan 10, 2024He 25 Higher Regional Court Of Dusseldorf, Grur , 279 Fulvestrant
Jan 10, 2024He 25A Machine Translation (En)
Jan 10, 2024He 24 Fachinformationen Repatha(R)
Jan 10, 2024He 23 Smpc Of Repatha(R)
Jan 10, 2024He 22 Website Https://Fachkreise.Amgen.De/Produkte/Repatha/Index
Jan 10, 2024He 21 Expert Declaration Prof. Klaus G. Parhofer
Jan 10, 2024He 20 F. Kronenberg Et Al., European Heart Journal () 43, 3925 3946
Jan 10, 2024He 1 EP3536712B1
Jan 10, 2024He 19 Wilson Et Al., Journal Of Clinical Lipidology () 13, 374 392
Jan 10, 2024He 18 V Bermudez Et. Al, American Journal Of Therapeutics 17, 263 273 (2
Jan 10, 2024He 17 Feature Analysis Patent In Suit
Jan 10, 2024He 16 Jama. ;302(4):412 423. Doi:10.1001/Jama..1063 (Including Online Supplement)
Jan 10, 2024He 15 Bennet Et Al, Arch Intern Med, VOL. 168, No. 6, ;
Jan 10, 2024He 14 Expert Report I By Emanuele Di Angelantonio From The European Opposition Proceedings (D64)
Jan 10, 2024He 13 Horton Et Al.,
Jan 10, 2024He 12 Nordestgaard Et Al, European Heart Journal, 31, ,
Jan 10, 2024He 11 Grounds For Defence To Nullity Action DATED 15 November
Jan 10, 2024He 10 Amgen S Nullity Action On Ep 004 DATED 3 August Filed Before The Federal Patent Court (3 Ni 21/23)
Jan 10, 2024Acknowledgement Of Lodging
Jan 10, 2024240110 Statement Of Claim Sig

More cases involving EP3536712B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APL_32715/2025Jul 14, 2025Regeneron Pharmaceuticals, Sanofi BiotechnologiesAmgen, Amgen Europe
UPC_COA_641/2025Jul 14, 2025Sanofi BiotechnologyAmgen
APL_32765/2025Jul 11, 2025Amgen, Amgen EuropeRegeneron Pharmaceuticals

More cases involving Sanofi Biotechnologies

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APL_32715/2025Jul 14, 2025Sanofi BiotechnologiesAmgen, Amgen Europe
APP_29861/2025Jun 27, 2025Sanofi Biotechnologies -
ORD_16586/2025Apr 4, 2025Sanofi BiotechnologiesAmgen, Amgen Europe

More cases involving Amgen

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_35200/2025Aug 21, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
APP_35086/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
APP_35087/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -